发明名称 |
UNIVERSAL INFLUENZA VACCINE BASED ON HETEROLOGOUS MULTIPLE M2E PROTEINS |
摘要 |
Disclosed are universal influenza A vaccines capable of providing broader crossprotection. The vaccine contains a fusion protein comprising tandem repeats of heterologous M2e epitope sequences that have been molecularly and genetically designed to provide broad cross-protection. The fusion protein may be incorporated into virus-like particles (VLPs) or a replicating live attenuated influenza virus vaccine, and administered alone or in combination with other influenza vaccines. |
申请公布号 |
US2015273048(A1) |
申请公布日期 |
2015.10.01 |
申请号 |
US201314440114 |
申请日期 |
2013.10.30 |
申请人 |
GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION |
发明人 |
Kang Sang-Moo;Kim Min-Chul |
分类号 |
A61K39/145;C07K14/005;C12N7/00 |
主分类号 |
A61K39/145 |
代理机构 |
|
代理人 |
|
主权项 |
1. A cross-protective influenza vaccine comprising a fusion protein immobilized on the surface of a virus-like particle (VLP) or in a secreted form,
wherein the fusion protein comprises tandem repeats of three or more heterologous influenza virus matrix protein 2 extracellular (M2e) domains, and wherein the vaccine is cross-protective against two or more subtypes of influenza A with or without the use of an adjuvant. |
地址 |
Atlanta GA US |